During the past decade, Allergy & Asthma Research Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 10 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergy & Asthma Research Center" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Shire" with 5 trials sponsored, "Meda Pharmaceuticals" with 3 trials sponsored, "Aerovance, Inc." with 1 trials sponsored and "Amneal Pharmaceuticals, LLC" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allergy & Asthma Research Center" #1 collaborator was "Novum Pharmaceutical Research Services" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Allergy & Asthma Research Center" are "Asthma" (8 trials), "Seasonal Allergic Rhinitis" (5 trials), "Hereditary Angioedema" (4 trials), "Chronic Rhinosinusitis" (2 trials) and "Nasal Polyps" (2 trials). Many other conditions were trialed in "Allergy & Asthma Research Center" in a lesser frequency.

Most popular intervention types in "Allergy & Asthma Research Center" are "Drug" (19 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Omalizumab" (4 trials), "C1 esterase inhibitor [human] (C1INH-nf)" (3 trials), "Lebrikizumab" (2 trials) and "fluticasone propionate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Allergy & Asthma Research Center" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Allergy & Asthma Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Allergy & Asthma Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy & Asthma Research Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".